Over the course of three years, 10 BIPOC artists will receive $150,000 and technical support through the Seed and Bloom: Detroit initiative. Jennifer, Nick and Dan Gilbert. (Gilbert Family Foundation.
The start of human dosing in a clinical trial Monday, plus a drug approval earlier this month, together offer the potential to reshape the treatment of the rare disease neurofibromatosis type 1 (NF1).
GREENSBORO, N.C. — For 18-year-old Sally Nagappan, living with neurofibromatosis type 1 — or NF1 — is all she’s ever known. Diagnosed at just six months old, Sally has spent her life navigating the ...
PITTSBURGH, April 16, 2025 /PRNewswire/ -- The Giorgio Foundation and the University of Pittsburgh announce the establishment of The Giorgio Foundation Endowed Chair in the School of Medicine's ...
Panelists discuss how neurofibromatosis type 1 (NF1) is typically diagnosed in early childhood using National Institutes of Health (NIH) clinical criteria, with genetic testing supporting unclear ...
CAMBRIDGE, England--(BUSINESS WIRE)--Healx, an AI-enabled, clinical-stage biotech company dedicated to rare diseases, today announced the first patient has been dosed in INSPIRE-NF1, a Phase 2 trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results